ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,794 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselSkyhawk Therapeutics Europe GmbH
Skyhawk Therapeutics Europe GmbH Logo
Verified· 2 sources

Skyhawk Therapeutics Europe GmbH

Summary

About the company

The core activity of Skyhawk Therapeutics is the development of small molecules that modify RNA expression, particularly for the treatment of diseases in the areas of neurology, oncology and fibrosis. The company uses its own SKYSTAR platform to identify and develop RNA targets, and works with various pharmaceutical companies in this process.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of RNA-modulating small-molecule therapeutics
Development of small molecules to modify RNA expression for neurological, oncological, fibrotic and other diseases; focus on targets that have been difficult to treat so far.
Platform for RNA-targeting drug discovery
Proprietary platform with SKYSTAR®, SKYLIBRARY™, SKYSEQ™ and SKYAI™ for prioritizing RNA targets, screening compounds and developing new drug candidates.
Development of an internal pipeline of drug candidates
Own pipeline with programs in neurological, neuromuscular, oncological and fibrotic indications; including SKY-0515 for Huntington’s Disease and additional preclinical programs.
Pharma partnerships for drug programs
Collaborations with pharmaceutical companies to develop targeted drug candidates, including biological insights, commercial perspectives and upfront payments.

Knowledge

No knowledge articles yet

Once Skyhawk Therapeutics Europe GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Skyhawk Therapeutics Europe GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Skyhawk Therapeutics Europe GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Skyhawk Therapeutics Europe GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60i
4057 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-264.191.062
Founded
2018 · 8 years
Last commercial register change
February 4, 2026
Employees
11 to 20

Similar companies

TT
TOLREMO therapeutics AG
Basel
MB
MabTree Biologics AG
Basel
IA
Intex-Biotech AG
Basel
LS
Latscha Schöllhorn Partner AG
Basel
AS
Accense S.A.
Basel
EB
ESC Biotech Swiss AG
Basel
GA
Galvita AG
Basel
IC
ICON Clinical Research (Switzerland) GmbH
Basel